InvestorsHub Logo
Followers 279
Posts 33345
Boards Moderated 1
Alias Born 11/14/2013

Re: Pyrrhonian post# 18140

Monday, 09/01/2014 3:19:33 PM

Monday, September 01, 2014 3:19:33 PM

Post# of 722133
CD4 count is a subset of the WBC count that NWBO will now critically account for at the end of the trial. My question is whether the screening process NWBO uses for WBC would necessarily screen out low CD4 patients? Am I confused here (excluding the issues regarding when the screening occurs)? I must admit, some current projects/distractions are hindering my literature review time for the present moment.

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News